Practice of Dapagliflozin Application in Patients with Type 2 Diabetes Mellitus

The article presents the results of using new antihyperglycemic drug — a selective inhibitor of the sodium-glucose cotransporter type 2 — dapagliflozin in patients with type 2 diabetes mellitus. The influence of this drug on the effectiveness of glycemic control, blood pressure level, lipid profile,...

Full description

Bibliographic Details
Main Authors: L.V. Shkala, Ya.I. Kleban, O.V. Cherpak, O.V. Shkala, O.A. Karapetian, T.H. Volkovska
Format: Article
Language:English
Published: Publishing House Zaslavsky 2015-08-01
Series:Mìžnarodnij Endokrinologìčnij Žurnal
Subjects:
Online Access:http://iej.zaslavsky.com.ua/article/view/75180